接触因-4通过激活粉样蛋白前体蛋白来抑制抗瘤T细胞的反应
Bu-Nam Jeon1, Sujeong Kim2, Yunjae Kim2
1Genome and Company, 8F Gwanggyo Flax Desian, 50 Changnyong-daero, 256beon-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do 16229, Republic of Korea.
Science immunology
|October 11, 2024
概括
研究人员将接触素-4 (CNTN4) 确定为一种新的免疫检查点. 阻断CNTN4或其受体粉样前体蛋白 (APP) 增强T细胞抗瘤活性,提供一种新的癌症免疫治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子医学是分子医学.
背景情况:
- 免疫检查点抑制剂 (ICI) 在癌症治疗中表现有前途,但仅对一小部分患者有益.
- 识别新的免疫检查点对于提高免疫疗法疗效至关重要.
- 接触素-4 (CNTN4) 在癌症免疫力中的免疫调节作用在很大程度上尚未被探索.
研究的目的:
- 研究接触素-4 (CNTN4) 在调节抗瘤免疫反应中的功能.
- 确定针对癌症免疫疗法的CNTN4-粉样蛋白前体蛋白 (APP) 轴的潜在向.
主要方法:
- 分析了瘤组织中的CNTN4表达.
- 研究了CNTN4和APP在T细胞上的相互作用.
- 在合成基因小鼠模型中开发并测试了抗CNTN4和抗APP抗体.
- 与患者预后和免疫标志物相关联的CNTN4水平.
主要成果:
- 在瘤组织中,CNTN4表达高,T细胞抗瘤功能受损.
- CNTN4与T细胞上的APP结合,抑制癌细胞-T细胞结合和T细胞受体信号传递.
- 抗CNTN4 (GENA-104A16) 和抗APP (5A7) 抗体促进了T细胞的反应,并在体内增加了瘤透淋巴细胞.
- 升高的CNTN4水平与预后不佳和细胞毒性免疫标志物减少相关.
结论:
- 该CNTN4-APP通路作为T细胞的抑制性免疫检查点.
- 准CNTN4或APP代表了增强癌症免疫疗法的有前途的治疗策略.
更多相关视频
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
22.4K
10:13Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
8.9K
相关概念视频
01:27Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
01:27Cytotoxic T Cells-mediated Immune Response
857
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
857
01:40Cell-mediated Immune Responses
67.5K
Overview
67.5K